SGCB and pulmonary arterial hypertension: Since its discovery, the structure of YC-1 has been used as a template for drug development efforts aimed at creating sGC stimulators, including for the drug riociguat (Bayer’s Adempas®) that is used in the treatment of pulmonary hypertension [9,32,33,34,35].